Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. [electronic resource]
Producer: 19990908Description: 1217-22 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Antimetabolites, Antineoplastic -- administration & dosage
- Bone Marrow Transplantation
- Child
- Child, Preschool
- Combined Modality Therapy
- Cytarabine -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Humans
- Leukemia -- drug therapy
- Male
- Middle Aged
- Recurrence
- Transplantation Conditioning
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.